| My Account | Subscribe | Contact Us | Donate |
Home
- The Edmonton Protocol and Me
- Olympia Dukakis and Her Husband Tackle Type 2
- Surfing with Type 1
- Behind the Wheel, But Still in Control
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Type 2 Issues Articles
Richard K. Bernstein fears that Regular insulin will be the next to vanish from the American market
Is Regular the Next to Go?
Feb 1, 2006
Richard K. Bernstein fears that Regular insulin will be the next to vanish from the American market.
“Sooner or later, they are going to discontinue Regular because of all the promotion given to the new analogues,” says Bernstein.
Bernstein prefers Regular to Humalog, because he feels it is more predictable and matches meal plans better for people who are following a lower-carbohydrate eating plan.
“But you have to wait 45 minutes for it to start working, which for some people is an inconvenience,” says Bernstein. “The greatest value I see in Humalog is for when you are eating out and you don’t know when you are going to be served, or if you are correcting a high BG and you want it to come down fast.”
When asked if Regular would be the next insulin to be pulled from the market, Novo Nordisk told Diabetes Health it does not comment on strategies or marketing practices for any of its products.
Eli Lilly told Diabetes Health that it regularly reviews its product portfolio and makes decisions based on patient demand, new innovations and market conditions. “However, we have no plans to discontinue Humulin R or Humulin NPH at this time.”
Categories: Insulin, Type 1 Issues, Type 2 Issues
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
Feb 1, 2006 -
Email to a Friend
Send a link to this page to your friends and colleagues.